BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T120000
DTEND;TZID=America/New_York:20260512T133000
DTSTAMP:20260320T152435Z
CREATED:20260320T152435Z
LAST-MODIFIED:20260320T152435Z
UID:3452-1778587200-1778592600@www.ctnnortheastnode.org
SUMMARY:Older Adults and Casino Gambling: Behaviors\, Motivations\, and Risk
DESCRIPTION:New England Addiction Technology Transfer Webinar \nLearn what motivates older adults to gamble and the factors that increase their risk for Gambling Disorder as this population evolves. Explore key implications for prevention and reducing gambling-related harm among older adults. \nClick to Register
URL:https://www.ctnnortheastnode.org/event/older-adults-and-casino-gambling-behaviors-motivations-and-risk/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T130000
DTEND;TZID=America/New_York:20260512T140000
DTSTAMP:20260209T174045Z
CREATED:20260209T174045Z
LAST-MODIFIED:20260209T174045Z
UID:3445-1778590800-1778594400@www.ctnnortheastnode.org
SUMMARY:A Practical Overview of Treating Cannabis Use in the Perinatal Period
DESCRIPTION:REGISTER NOW \nABOUT THE TRAINER: \nDr. Lindy Howe is a postdoctoral research fellow at the Center for Alcohol and \nAddiction Studies at Brown University. Lindy’s research interests center on \nsubstance use\, particularly examining the interplay between psychopathology\, \ndecision-making\, and situational factors of alcohol and cannabis use through \necological momentary assessment. Her emerging research interests also explore \nthe interaction of substance use with perinatal mental health\, specifically focusing \non the role providers play in shaping perceptions of cannabis use before\, during\, \nand after pregnancy\, the factors contributing to the return of substance use \npostpartum\, and the impact of cannabis and alcohol use on postpartum mental \nhealth outcomes. \n  \nDESCRIPTION: \nThis training provides an evidence-based framework for addressing cannabis use in \nperinatal populations\, focusing on key clinical considerations and the management of co- \noccurring mental health factors. Through the discussion of applied case examples\, \nparticipants will learn to navigate complications and implement practical interventions \nwithin pregnancy and postpartum treatment settings. \n  \nLEARNING OBJECTIVES: \nDescribe evidence-based interventions for addressing cannabis use during pregnancy \nand the postpartum period. \nIdentify key clinical considerations\, complications\, and co-occurring mental health \nfactors relevant to treating cannabis use in perinatal populations. \nApply a general framework for approaching cannabis use within perinatal treatment \nsettings (e.g.\, mental health and substance use care) through discussion of applied case \nexamples. \n  \nREGISTER NOW
URL:https://www.ctnnortheastnode.org/event/a-practical-overview-of-treating-cannabis-use-in-the-perinatal-period/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260513T170000
DTEND;TZID=America/New_York:20260513T180000
DTSTAMP:20260504T201144Z
CREATED:20260504T201144Z
LAST-MODIFIED:20260504T201144Z
UID:3462-1778691600-1778695200@www.ctnnortheastnode.org
SUMMARY:Medetomidine Impacts on Clinical Management and Systems of Care
DESCRIPTION:ORN Spring 2026 Hot Topics in Addiction Medicine\n\nDescription: \nMedetomidine\, a highly potent veterinary alpha-2 adrenergic agonist\, has recently emerged as a significant adulterant within the U.S. illicit opioid supply. This presentation entitled will review the introduction of medetomidine in the U.S. drug supply\, the pharmacology and clinical effects of medetomidine\, and the distinguishing features of medetomidine toxicity and withdrawal. We will outline emerging treatment strategies emphasizing early\, aggressive alpha-2 agonist therapy; nuanced antiemetic approaches; when and how to escalate to IV dexmedetomidine; and approaches to concurrent opioid withdrawal management. Participants will gain insight into diagnostic challenges\, observation and disposition considerations\, and strategies for system-level preparedness. \nLearning Objectives:\n\nDescribe the emergence of medetomidine as an illicit drug adulterant and its impact on overdose toxicity and withdrawal presentations.\nRecognize the clinical features of medetomidine toxicity and differentiate medetomidine withdrawal from withdrawal syndromes.\nApply evidence-informed strategies for early\, aggressive management of medetomidine withdrawal\, including the use of alpha-2 agonists and antiemetic therapies.\nIdentify system-level challenges posed by medetomidine and outline approaches to multidisciplinary coordination.\n\nMichael Lynch\, MD \nREGISTER
URL:https://www.ctnnortheastnode.org/event/medetomidine-impacts-on-clinical-management-and-systems-of-care/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260520T120000
DTEND;TZID=America/New_York:20260520T130000
DTSTAMP:20260507T170630Z
CREATED:20260507T170630Z
LAST-MODIFIED:20260507T170630Z
UID:3465-1779278400-1779282000@www.ctnnortheastnode.org
SUMMARY:Dual and Polytobacco Product Use in the Context of Tobacco Research and Regulation
DESCRIPTION:Vermont Center on Behavior and Health Monthly Lecture Series \nLauren Pacek\, PhD\, is an Assistant Professor at Rutgers Robert Wood Johnson Medical School and a core faculty member at the Rutgers Institute for Nicotine and Tobacco Studies. An epidemiologist trained at Johns Hopkins and Duke\, she previously served as faculty at Duke and as an epidemiologist for the FDA Center for Tobacco Products. Her NIH-funded research focuses on tobacco regulatory science and smoking cessation interventions\, particularly for people living with HIV and those with co-occurring mental health disorders. With 101 peer-reviewed publications\, her work is dedicated to informing public health policy and improving outcomes for vulnerable populations. \n\n\n\nREGISTER FOR WEBINAR
URL:https://www.ctnnortheastnode.org/event/dual-and-polytobacco-product-use-in-the-context-of-tobacco-research-and-regulation/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260610T120000
DTEND;TZID=America/New_York:20260610T130000
DTSTAMP:20260604T164251Z
CREATED:20260604T164251Z
LAST-MODIFIED:20260604T164251Z
UID:3466-1781092800-1781096400@www.ctnnortheastnode.org
SUMMARY:From Evidence to Practice: Contingency Management for the Treatment of Stimulant and Other Substance Use Disorders
DESCRIPTION:From Evidence to Practice: Contingency Management for the Treatment of Stimulant and Other Substance Use Disorders\nPresenters: \nStephen T. Higgins\, PhD\, Director of UVM’s Vermont Center on Behavior and Health (VCBH)\nTyler G. Erath\, PhD\, Assistant Professor in the Department of Psychiatry and VCBH \n\nThis presentation will discuss evidence to support the effectiveness of contingency management (CM) as a treatment for stimulant use disorder and other substance use disorders (SUDs)\, review the current landscape of CM implementation in the United States\, describe current challenges to using CM including in rural healthcare settings\, and review the CM certificate course now available through VCBH and UVM’s Professional and Continuing Education. \nLearning objectives: \n\n\nDefine and review the evidence of CM as a treatment for stimulant use disorder and other SUDs\nOutline the evidence-based components of CM interventions\nProvide a 10\,000-foot overview of the current CM implementation landscape in the US\nDescribe current contextual determinants to using CM and some efforts to overcome barriers including in rural healthcare environments\nReview the UVM CM certificate course now available through VCBH and UVM‘s Professional and Continuing Education\n\nRegister for Webinar
URL:https://www.ctnnortheastnode.org/event/from-evidence-to-practice-contingency-management-for-the-treatment-of-stimulant-and-other-substance-use-disorders/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
END:VCALENDAR